Management of cardiogenic shock complicating myocardial infarction: An update 2019

Holger Thiele*, E. Magnus Ohman, Suzanne De Waha-Thiele, Uwe Zeymer, Steffen Desch

*Corresponding author for this work
46 Citations (Scopus)


Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping. This updated review will outline the management of CS complicating AMI with major focus on state-of-the art treatment.

Original languageEnglish
JournalEuropean Heart Journal
Issue number32
Pages (from-to)2671-2683
Number of pages13
Publication statusPublished - 21.08.2019


Dive into the research topics of 'Management of cardiogenic shock complicating myocardial infarction: An update 2019'. Together they form a unique fingerprint.

Cite this